Works matching 5q minus syndrome
Results: 7
Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
- Published in:
- 2010
- By:
- Publication type:
- Letter
karla.svobodova@vfn.cz Inzerce A151006201 ? 136 TRANSFUZE HEMATOL. DNES 21, 2015 Kazuistika (ne)chelatovaného polytransfundovaného pacienta s 5q minus syndromem.
- Published in:
- Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2015, v. 21, n. 3, p. 136
- By:
- Publication type:
- Article
5qMinus Myelodysplasia Associated with Multiple Epithelioid Granulomas within Conventional Renal Cell Carcinoma.
- Published in:
- Case Reports in Pathology, 2012, p. 1, doi. 10.1155/2012/138126
- By:
- Publication type:
- Article
Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 1, doi. 10.1016/j.clml.2012.09.016
- By:
- Publication type:
- Article
Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan.
- Published in:
- Malaysian Journal of Pathology, 2023, v. 45, n. 3, p. 405
- By:
- Publication type:
- Article
Jsme oprávněni řadit nemocné s dvěma samostatnými buněčnými klony a to s delecí 5q a s trizomií 8 jako podskupinu myelodysplastického syndromu typu 5q- syndromu?
- Published in:
- Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2014, v. 20, n. 1, p. 25
- By:
- Publication type:
- Article
Lenalidomide in multiple myeloma: current experimental and clinical data.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 4, p. 279, doi. 10.1111/j.1600-0609.2011.01735.x
- By:
- Publication type:
- Article